Blaine Labs Inc recalls TRIFLUENT PHARMA TRIDERGEL Wound Care Gel
- Recalling company
- Blaine Labs Inc
- Product
- TRIFLUENT PHARMA TRIDERGEL Wound Care Gel, (Benzalkonium Chloride 0.1%), 1.0 fl oz, (29.6 mL) bottle with long pointy cap, Manufactured for: Trifluent Pharma, LLC. San Antonio, TX 78213. NDC 73352-520-01.
- Reason
- CGMP Deviations: product manufactured in the same facility under the same conditions as the product found to be contaminated
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Apr 8, 2026
- Reported
- Jul 8, 2026
- Distribution
- Nationwide in the USA
- Status
- Ongoing
- Quantity
- 519 - 1 oz bottles
- Lot / codes
- Lot #: BL3435, Exp. 11/06/26
- Company location
- Santa Fe Springs, CA
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0693-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0693-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.